These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26216866)

  • 1. [Aplastic anemia: Current state of diagnosis and treatment].
    Schrezenmeier H; Körper S; Höchsmann B
    Internist (Berl); 2015 Sep; 56(9):989-99. PubMed ID: 26216866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Treatment of Aplastic Anemia.
    Peslak SA; Olson T; Babushok DV
    Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in treatment of aplastic anemia.
    Shin SH; Lee SE; Lee JW
    Korean J Intern Med; 2014 Nov; 29(6):713-26. PubMed ID: 25378968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.
    Schrezenmeier H; Körper S; Höchsmann B
    Expert Rev Hematol; 2015 Feb; 8(1):89-99. PubMed ID: 25572607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
    Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
    Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the refractory aplastic anemia patient: what are the options?
    Marsh JC; Kulasekararaj AG
    Hematology Am Soc Hematol Educ Program; 2013; 2013():87-94. PubMed ID: 24319168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
    Kook H; Chung NG; Kang HJ; Im HJ
    Int J Hematol; 2016 Apr; 103(4):380-6. PubMed ID: 26894608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired aplastic anemia].
    Yamazaki H
    Rinsho Ketsueki; 2016 Feb; 57(2):91-7. PubMed ID: 26935624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.
    Scheinberg P; Nunez O; Young NS
    Br J Haematol; 2006 Jun; 133(6):622-7. PubMed ID: 16704436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making therapeutic decisions in adults with aplastic anemia.
    Marsh J
    Hematology Am Soc Hematol Educ Program; 2006; ():78-85. PubMed ID: 17124044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reference guide for the treatment of aplastic anemia: key points of the 2022 revision].
    Yamazaki H
    Rinsho Ketsueki; 2023; 64(9):892-899. PubMed ID: 37793863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia.
    Ahmed P; Chaudhry QU; Raza S; Mahmood SK; Satti TM; Anwar M; Altaf C; Shahbaz N; Satti HS
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):553-9. PubMed ID: 22980607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of aplastic anemia after failure of frontline immunosuppression.
    Pierri F; Dufour C
    Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
    [No Abstract]   [Full Text] [Related]  

  • 17. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplant in severe aplastic anemia.
    Atta EH; de Sousa AM; Schirmer MR; Bouzas LF; Nucci M; Abdelhay E
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1876-82. PubMed ID: 22796534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation.
    Passweg JR; Marsh JC
    Hematology Am Soc Hematol Educ Program; 2010; 2010():36-42. PubMed ID: 21239768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
    Marotta S; Pagliuca S; Risitano AM
    Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cutting edge of aplastic anemia treatment].
    Obara N
    Rinsho Ketsueki; 2017; 58(10):1851-1859. PubMed ID: 28978824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.